Stephen Glover
Chief Executive Officer at ZYVERSA THERAPEUTICS, INC.
Net worth: 209 061 $ as of 2024-04-29
Stephen Glover active positions
| Companies | Position | Start | End |
|---|---|---|---|
| PDS BIOTECHNOLOGY CORPORATION | Independent Dir/Board Member | 2019-04-01 | - |
| Chairman | - | - | |
| Director/Board Member | 2019-04-01 | - | |
| ZYVERSA THERAPEUTICS, INC. | Chief Executive Officer | 2022-11-30 | - |
| Chairman | 2022-11-30 | - | |
| Founder | 2013-12-31 | - | |
| President | 2022-11-30 | - | |
| AMBRX INC | Chairman | 2023-04-30 | - |
| Inflamacore LLC | Director/Board Member | - | - |
Ambrx Biopharma, Inc.
 Ambrx Biopharma, Inc. BiotechnologyHealth Technology Ambrx Biopharma Cayman, Inc. operates as a clinical-stage biologics company. It focuses on discovering and developing a novel class of engineered precision biologics using its proprietary expanded genetic code technology platform that allows it to incorporate, in a site-specific manner, synthetic amino acids that do not exist in nature into proteins within living cells. The company was founded in January 2003 and is headquartered in La Jolla, CA. | Chairman | 2023-05-17 | - |
| Wallace H. Coulter Foundation | Director/Board Member | - | - |
Two B Pharma
 Two B Pharma Pharmaceuticals: GenericHealth Technology Two B Pharma is an Egyptian clinical-stage pharmaceutical company that develops drugs. | Director/Board Member | - | - |
Asclepius Life Sciences Fund LP
 Asclepius Life Sciences Fund LP Financial ConglomeratesFinance Asclepius Life Sciences Fund LP provides pooled investment funds. The company was founded by Stephen C. Glover and Steven Gerst and is headquartered in New York, NY. | Director/Board Member | - | - |
| Founder | - | - | |
| Corporate Officer/Principal | - | - | |
ZyVersa Therapeutics Operating, Inc.
 ZyVersa Therapeutics Operating, Inc. Pharmaceuticals: MajorHealth Technology ZyVersa Therapeutics Operating, Inc. operates as a specialty pharmaceutical company, which develops and commercializes prescription pharmaceutical products. The firm focuses on developing products for the treatment of men?s health, as well as for other markets where current therapies are suboptimal and underdeveloped. It offers VAR 100, an oral formulation of native testosterone to treat male hypogonadism; and VAR 200 that minimizes and prevents kidney cell damage, and improves focal segmental glomerulosclerosis prognosis. The company was founded by Stephen C. Glover and Shawn M. Titcomb in 2014 and is headquartered in Weston, FL. | Chairman | - | - |
| Chief Executive Officer | 2014-02-28 | - | |
| Founder | 2014-02-28 | - | |
| Director/Board Member | 2014-02-28 | - | |
| President | - | - |
Career history of Stephen Glover
Former positions of Stephen Glover
| Companies | Position | Start | End |
|---|---|---|---|
| ░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░░░░ ░░░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░ ░░░░░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ | - | - |
| ░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ | - | - |
| ░░░░░ ░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
| ░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
Training of Stephen Glover
| Illinois State University | Undergraduate Degree |
Statistics
International
| United States | 17 |
| South Korea | 2 |
| Egypt | 2 |
Operational
| Director/Board Member | 8 |
| Chairman | 6 |
| President | 5 |
Sectoral
| Health Technology | 12 |
| Consumer Services | 2 |
| Consumer Durables | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 5 |
|---|---|
| INSMED INCORPORATED | Health Technology |
| PDS BIOTECHNOLOGY CORPORATION | Health Technology |
| INCON CO.,LTD. | Consumer Durables |
| COHERUS BIOSCIENCES, INC. | Health Technology |
| ZYVERSA THERAPEUTICS, INC. | Health Technology |
| Private companies | 12 |
|---|---|
Andrx Corp.
 Andrx Corp. Pharmaceuticals: MajorHealth Technology Andrx Corp. developed, manufactured, and marketed oral pharmaceutical products. The company was founded in August, 1992 and was headquartered in Davie, FL. | Health Technology |
Auriga Laboratories, Inc.
 Auriga Laboratories, Inc. BiotechnologyHealth Technology Auriga Laboratories, Inc. is a specialty pharmaceutical company, which is engaged in the commercialization, licensing and development of prescription pharmaceutical products. Its products are focused in the respiratory, dermatology CNS and anti-infective therapeutic categories and are marketed to primary care physicians, pediatricians, dermatologists, urologists, psychiatrists and rheumatologists. The company was founded on April 12, 2005 and is headquartered in Camarillo, CA. | Health Technology |
| Insmed Therapeutic Proteins | |
ZyVersa Therapeutics Operating, Inc.
ZyVersa Therapeutics Operating, Inc. Pharmaceuticals: MajorHealth Technology ZyVersa Therapeutics Operating, Inc. operates as a specialty pharmaceutical company, which develops and commercializes prescription pharmaceutical products. The firm focuses on developing products for the treatment of men?s health, as well as for other markets where current therapies are suboptimal and underdeveloped. It offers VAR 100, an oral formulation of native testosterone to treat male hypogonadism; and VAR 200 that minimizes and prevents kidney cell damage, and improves focal segmental glomerulosclerosis prognosis. The company was founded by Stephen C. Glover and Shawn M. Titcomb in 2014 and is headquartered in Weston, FL. | Health Technology |
Asclepius Life Sciences Fund LP
Asclepius Life Sciences Fund LP Financial ConglomeratesFinance Asclepius Life Sciences Fund LP provides pooled investment funds. The company was founded by Stephen C. Glover and Steven Gerst and is headquartered in New York, NY. | Finance |
| Inflamacore LLC | |
Two B Pharma
Two B Pharma Pharmaceuticals: GenericHealth Technology Two B Pharma is an Egyptian clinical-stage pharmaceutical company that develops drugs. | Health Technology |
| Wallace H. Coulter Foundation | Commercial Services |
Ambrx Biopharma, Inc.
Ambrx Biopharma, Inc. BiotechnologyHealth Technology Ambrx Biopharma Cayman, Inc. operates as a clinical-stage biologics company. It focuses on discovering and developing a novel class of engineered precision biologics using its proprietary expanded genetic code technology platform that allows it to incorporate, in a site-specific manner, synthetic amino acids that do not exist in nature into proteins within living cells. The company was founded in January 2003 and is headquartered in La Jolla, CA. | Health Technology |
Ambrx, Inc.
 Ambrx, Inc. Pharmaceuticals: MajorHealth Technology Ambrx, Inc. engages in discovering and developing of protein therapeutics. It offers non-native amino acids through expanded genetic code to both generate novel bio-therapeutics. The company was founded by Richard DiMarchi, Peter G. Schultz, and Troy E. Wilson on April 15, 2003 and is headquartered in La Jolla, CA. | Health Technology |
Andrx Laboratories, Inc.
 Andrx Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Andrx Laboratories, Inc. was a specialty pharmaceuticals company that was acquired by Watson Pharmaceuticals in November 2006. It engaged in the development and commercialization of controlled-release branded pharmaceuticals and generics. The company was founded in 1995 and was headquartered in Fort Lauderdale, FL. | Health Technology |
| Watson Therapeutics, Inc. |
- Stock Market
- Insiders
- Stephen Glover
- Experience
